Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
75.6M
-
Number of holders
-
220
-
Total 13F shares, excl. options
-
75.1M
-
Shares change
-
+1.43M
-
Total reported value, excl. options
-
$3.53B
-
Value change
-
+$109M
-
Put/Call ratio
-
0.09
-
Number of buys
-
132
-
Number of sells
-
-199
-
Price
-
$46.99
Significant Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (SWTX) as of Q2 2025
406 filings reported holding SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q2 2025.
SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (SWTX) has 220 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 75.1M shares
of 75.6M outstanding shares and own 99.26% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (7.26M shares), VANGUARD GROUP INC (7.13M shares), GLAZER CAPITAL, LLC (4.11M shares), FIL Ltd (3.01M shares), STATE STREET CORP (2.99M shares), TIG Advisors, LLC (2.61M shares), GOLDMAN SACHS GROUP INC (2.28M shares), Beryl Capital Management LLC (2.12M shares), Magnetar Financial LLC (2.05M shares), and First Trust Capital Management L.P. (1.94M shares).
This table shows the top 220 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.